Evidence map›Paper›PMID 11134312›Full record

ArticleJournal of virology2001

Molecular characterization of Bombyx mori cytoplasmic polyhedrosis virus genome segment 4.

K Ikeda, S Nagaoka, S Winkler, K Kotani, H Yagi, K Nakanishi, S Miyajima, J Kobayashi, H Mori

Abstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
8.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

K IkedaDepartment of Applied Biology, Kyoto Institute of Technology, Kyoto 606-8585, Japan.
S Nagaoka
S Winkler
K Kotani
H Yagi
K Nakanishi
S Miyajima
J Kobayashi
H Mori
Kyoto Institute of Technology · JPMie University · JPTufts University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complete nucleotide sequence of the genome segment 4 (S4) of Bombyx mori cytoplasmic polyhedrosis virus (BmCPV) was determined. The 3,259-nucleotide sequence contains a single long open reading frame which spans nucleotides 14 to 3187 and which is predicted to encode a protein with a molecular mass of about 130 kDa. Western blot analysis showed that S4 encodes BmCPV protein VP3, which is one of the outer components of the BmCPV virion. Sequence analysis of the deduced amino acid sequence of BmCPV VP3 revealed possible sequence homology with proteins from rice ragged stunt virus (RRSV) S2, Nilaparvata lugens reovirus S4, and Fiji disease fijivirus S4. This may suggest that plant reoviruses originated from insect viruses and that RRSV emerged more recently than other plant reoviruses. A chimeric protein consisting of BmCPV VP3 and green fluorescent protein (GFP) was constructed and expressed with BmCPV polyhedrin using a baculovirus expression vector. The VP3-GFP chimera was incorporated into BmCPV polyhedra and released under alkaline conditions. The results indicate that specific interactions occur between BmCPV polyhedrin and VP3 which might facilitate BmCPV virion occlusion into the polyhedra.

Indexed as

Amino Acid SequenceAnimalsBase SequenceBlotting, WesternBombyxCapsidCapsid ProteinsGreen Fluorescent ProteinsLuminescent ProteinsMolecular Sequence DataRecombinant Fusion ProteinsReoviridaeSequence AlignmentSequence Analysis, DNACapsid ProteinsGreen Fluorescent ProteinsLuminescent ProteinsRecombinant Fusion ProteinsVP3 protein, Bombyx mori cytoplasmic polyhedrosis virus

Identifiers

PMID11134312
PMCPMC113995
OpenAlexW1970669060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.